Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05973890 · ClinicalTrials.gov registry record · NA
Community-based Communication for Blood Donation in Ghana
A NA study of Increase Repeat Blood Donation Attempts Among First-time Donors, sponsored by University of Minnesota.
- Active
- Registry status
- NA
- Development phase
- 882
- Enrollment target
- 1
- Study location
NCT05973890: Active NA study of Increase Repeat Blood Donation Attempts Among First-time Donors, sponsored by University of Minnesota.
NCT05973890 is a NA study of Increase Repeat Blood Donation Attempts Among First-time Donors that is active but no longer recruiting, run by University of Minnesota. The registered enrollment target is 882 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05973890, a NA study of Increase Repeat Blood Donation Attempts Among First-time Donors, is active but no longer recruiting, sponsored by University of Minnesota.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 882 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized controlled trial to evaluate the effectiveness of the WhatsApp groups or docudrama compared to a control group (usual engagement with blood services) on repeat blood donation attempts among first-time blood donors in Ghana. Secondary outcomes will be blood donor retention, blood donation knowledge, attitudes, beliefs, motivations, intention to donate, and relatedness as potential mediators of blood donation behavior among first-time blood donors. The RCT will have three arms: 1. WhatsApp; 2. docudrama; 3. control. Each participant in the WhatsApp and docudrama arms will receive the intervention for 14 months. Participants in the control arm will receive standard national blood donation communications and be followed for 14 months. Actualized blood donation is possible every four months using NBSG guidelines; consequently, participants may make multiple blood donation attempts. Return blood donation attempts will be evaluated using the Southern Zonal Blood Center (SZBC) records (primary outcome) and participant self-report (secondary outcome) at 7 months and 14 months. Secondary measures will be evaluated at baseline, 7 and 14 months from enrollment. The duration of the RCT will be 26 months allowing for 12 months to achieve enrollment goals and 14 months of follow-up for the last individual enrolled.
Primary Outcome
The primary outcome for the RCT will be the number of blood donation attempts
Conditions Studied
Interventions
- BEHAVIORAL WhatsApp
- BEHAVIORAL docudrama
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 882 participants |
| Start Date | 2024-01-15 |
| Est. Completion | 2026-03-30 |
| Phase | NA |
What the registry record for NCT05973890 still lists
NCT05973890 is an interventional study that assigns participants to a tested intervention. The registered 882 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (37% lower).
The record links to 1 condition, with Increase Repeat Blood Donation Attempts Among First-time Donors appearing as the primary indexed condition, and to 2 interventions - of which WhatsApp is the first listed.
NCT05973890 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05973890 about?
NCT05973890 is a clinical study titled "Community-based Communication for Blood Donation in Ghana". A randomized controlled trial to evaluate the effectiveness of the WhatsApp groups or docudrama compared to a control group (usual engagement with blood services) on repeat blood donation attempts among first-time blood donors in Ghana. Secondary outcomes will be blood donor retention, blood donatio...
What is the current status of trial NCT05973890?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 882 participants. The study started on 2024-01-15. Estimated completion is 2026-03-30.
What conditions does trial NCT05973890 study?
This clinical trial studies the following conditions: Increase Repeat Blood Donation Attempts Among First-time Donors.
What interventions are being tested in trial NCT05973890?
The interventions under investigation include: WhatsApp (BEHAVIORAL), docudrama (BEHAVIORAL).
Who is sponsoring clinical trial NCT05973890?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05973890 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05973890's enrollment target sits among peer trials
882 130th of 2000 higher than 1,871 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07196748 · 882 participants · Phase 3
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- NCT05174286 · 880 participants · NA
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
- NCT05454280 · 880 participants · Phase 3
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
- NCT05525663 · 880 participants · NA
Physical Rehabilitation for Older Patients With Acute Heart Failure With Preserved Ejection Fraction
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI